Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Dorothy Brooks

FORGOTTEN HISTORY: Fda priority voucher program promising drug decisions within two months reportedly stalls as hhs says pilot continues - The Untold Story

The Food and Drug Administration has quietly stopped advancing its Commissioner's National Priority Voucher program, which promised drug decisions within one to two months instead of the usual 10 to 12, Reuters reported Nov. 12, citing sources. FDA leadership has told companies the program is not moving forward, though applications technically remain open, according to Pharmaceutical Technology's summary of the report.

The Department of Health and Human Services disputes that framing. HHS and FDA spokesperson Emily Hilliard said the pilot is ongoing and that the agency is reviewing feedback from a June public hearing to refine it.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.